Lonza Bend Inc.

Form 483 issued August 5, 2022 · Bend, Oregon

Inspection
Jul 25 – Aug 5, 2022
Observations
1
Pages
3
FEI number
3003722743

In short: On August 5, 2022, FDA issued a Form 483 with 1 observation to Lonza Bend Inc. in Bend, Oregon (FEI 3003722743) after an inspection that ran Jul 25 – Aug 5, 2022. The investigators were Crystal Monroy and Nathaniel B. Phillips-Sylvain. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Investigations of an unexplained discrepancy did not extend to other batches of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lonza Bend Inc.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Lonza Bend Inc.?

Crystal Monroy and Nathaniel B. Phillips-Sylvain are named on this Form 483, for the inspection of Jul 25 – Aug 5, 2022. Each investigator has a profile showing what they cite most.

When was Lonza Bend Inc. inspected by FDA?

The inspection ran Jul 25 – Aug 5, 2022, and the Form 483 is dated August 5, 2022.

How do I get the full Form 483 for Lonza Bend Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free